Cargando…

IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells

There are mixed reports on the role that IGFBP-2 plays in cancer progression, with some indicating a tumour suppressive role and others showing that IGFBP-2 may act as an oncogene. These apparent contradictions may be context and tissue specific. In this study we determined the role that IGFBP-2 pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Zhen, Gillatt, David, Rowe, Edward, Koupparis, Anthony, Holly, Jeff M.P., Perks, Claire M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925026/ https://www.ncbi.nlm.nih.gov/pubmed/31903164 http://dx.doi.org/10.18632/oncotarget.27355

Ejemplares similares

IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
por: Mansor, Rehanna, et al.
Publicado: (2020)

Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells
por: Mansor, Rehanna, et al.
Publicado: (2023)

Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2
por: Biernacka, K M, et al.
Publicado: (2016)

Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide
por: Perks, Claire M., et al.
Publicado: (2011)

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
por: Takahashi, Shin-Ichiro, et al.
Publicado: (2022)

Lifespan extension by increased expression of the Drosophila homologue of the IGFBP7 tumour suppressor
por: Alic, Nazif, et al.
Publicado: (2011)

Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial
por: Hackshaw-McGeagh, Lucy, et al.
Publicado: (2016)

Interaction between GRP78 and IGFBP-3 Affects Tumourigenesis and Prognosis in Breast Cancer Patients
por: Zielinska, Hanna A., et al.
Publicado: (2020)

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska, Hanna A, et al.
Publicado: (2015)

Microsatellite instability and chemosensitivity in solid tumours
por: Cherri, Sara, et al.
Publicado: (2022)

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
por: Lee, Ying-Ying, et al.
Publicado: (2018)

A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1
por: Biernacka, K.M., et al.
Publicado: (2023)

Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-β) in normal vs cancerous breast epithelial cells
por: McCaig, C, et al.
Publicado: (2002)

RNA helicase DHX15 acts as a tumour suppressor in glioma
por: Ito, Shingo, et al.
Publicado: (2017)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines
por: Koobotse, Moses, et al.
Publicado: (2018)

Gastric cancer--the recognition of a chemosensitive tumour.
por: Cunningham, D.
Publicado: (1988)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
por: Kingshott, Georgina, et al.
Publicado: (2021)

Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome
por: Vestey, Sarah B, et al.
Publicado: (2005)

IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes
por: Lay, Abigail C., et al.
Publicado: (2021)

MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer
por: Yao, Hui, et al.
Publicado: (2019)

Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men
por: Gunnell, D, et al.
Publicado: (2003)

Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2
por: Al Qahtani, Athba, et al.
Publicado: (2017)

IGFBP2 Plays an Essential Role in Cognitive Development during Early Life
por: Khan, Shumsuzzaman, et al.
Publicado: (2019)

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Micol, Jean-Baptiste, et al.
Publicado: (2017)

Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
por: Holly, Jeff M. P., et al.
Publicado: (2013)

Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells
por: Zeng, Li, et al.
Publicado: (2014)

Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential
por: Holly, Jeff M. P., et al.
Publicado: (2019)

The Neglected Insulin: IGF-II, a Metabolic Regulator with Implications for Diabetes, Obesity, and Cancer
por: Holly, Jeff M. P., et al.
Publicado: (2019)

The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
por: Quinn, P. K., et al.
Publicado: (1992)

Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5‐mediated p53 degradation blockage
por: Li, Juan, et al.
Publicado: (2022)

Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression
por: Fumarola, Stefania, et al.
Publicado: (2020)

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours
por: Jenkinson, Michael D., et al.
Publicado: (2006)

Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines
por: Kim, Taek Sang, et al.
Publicado: (2017)

The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.
por: Cowan, R., et al.
Publicado: (1997)

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel
por: Uzoh, C C, et al.
Publicado: (2011)

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
por: Srivastava, K., et al.
Publicado: (2023)

The influence of sample source and cell concentration on the in vitro chemosensitivity of haematological tumours.
por: Bird, M. C., et al.
Publicado: (1986)

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle
por: Holly, Jeff M. P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptfqsjc4gss7to6hdt39gaj6tb